|
|
|
Summary Nov. 12, 2008 | The economic environment is terrible—full stop. The financial devastation we are suffering with the echo boom of the credit crisis will be felt for many years.
|
Summary Grappling with the Next-Gen Data Glut
|
Summary Nov. 6, 2008 | The economic environment is terrible—full stop. The financial devastation we are suffering with the echo boom of the credit crisis will be felt for many years.
|
Summary Bio-IT World Weekly Update - Sept. 30, 2008
|
Summary Studies Suggest Cancer Pathways Are Best Targets
|
Summary Bio-IT World | It has been shown over the many investment cycles that some of the most compelling companies are born in the most turbulent of economic times. As bad as it is now, economic cycles do just that – cycle.
|
Big Blue continues to weather industry storms and come out on top. By John Russell Sept. 5, 2008 | Trying to describe in a single story the full scope of IBM’s Life Sciences and Healthcare activities and related work being done
|
Cover Story The Platform Diet Nicolas Saccomano, Pfizer's head of technology for R+D talks about dropping attrition rates, finding new talent, curbing the company's appetite for new tools - and empowering scientists with higher-quality data. Tackling cGMP; A Better Way to Innovate PHARMA-IT - Spe
|
Dec. 17, 2007 | Venture capitalists need to go back to school. It is that simple. Some of our best, most innovative, most promising investment opportunities are coming from campuses of many of the universities in our back yards. In fact entrepreneurs would also be well-served going back to school. In addition to
|
Tuesday, June 5, 2007 | Bio-ITWorld.com | Archives | Advertising | Your Account | CHI Conferences | Subscribe |
|
May 15, 2007 | Perhaps the single greatest task of being a venture capitalist involves recruiting for our portfolio companies. Those who are very good at it build very successful companies and serve as a real source of value to the entrepreneurs we back. An important aspect of recruiting is being conversant with
|
Tuesday, April 10, 2007 | Bio-ITWorld.com | Archives | Advertising | Your Account | CHI Conferences | Subscribe |
|
March 12, 2007 | A few months ago my firm invested in two diagnostic companies and we were very much not alone. In the first half of 2006, nearly $300 million of venture capital flowed into the United States and European diagnostics industries, which greatly eclipsed the amount invested in 2005. Anecdotally the
|
Predictive Biosciences announced today it has secured $10 million in Series A financing. Highland Capital Partners and IDG Ventures Boston co-led the investment in the company, which was jointly founded by the investors, leading entrepreneurs and internationally renowned scientists. In conjunction with the funding,
|
What Use Is the $1000 Genome?
Michael A. Greeley
Last month, at an industry conference, I heard a number of distinguished speakers discuss the prospects for the $1,000 genome and the critical path to get there. Everyone in the audience seemed excited and asked many compelling questions to sort out
|
Shaping a Web That Better Serves Humanity
What Use Is the $1000 Genome?
Abbott Buys Kos Pharma for $3.7 Billion
Tuesday, Nov 7, 2006
Bio-IT World News Bulletin Subscribe Advertising Your Account
|
Oct. 16, 2006 | Last month, at an industry conference, I heard a number of distinguished speakers discuss the prospects for the $1,000 genome and the critical path to get there. Everyone in the audience seemed excited and asked many compelling questions to sort out exactly when we would arrive at that point and
|
Science Publishing and the Web
Kevin Davies Earlier this year, Bio-IT World introduced a regular column in the magazine, "Science and the Web," which explores the surging interest in topics such as the Semantic Web, Web 2.0, social networking, wikis, mashups, and so on. These are poised to radically
|
Pfizer Names Jeffrey B. Kindler CEO Security Survey Notes Data Threats Science Publishing and the Web Tuesday, Aug 1, 2006 Bio-IT World News Bulletin Subscribe Advertising Your Account
|
July | August 2006 | Arguably, the company financing model is broken. Someone recently quipped that there “is a monsoon of capital, but entrepreneurs are dying of thirst.” Ironically, startups continue to have a very challenging time raising a seed or Series A round of financing, while later stage companies are now
|
The Role of Analytics in Transforming Healthcare Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders. Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are: - Potentially stunning return on investment at multiple levels.
- A 500%, or better, increase in application development time by directly executing business requirements
- Improved customer retention
- A 50% possible reduction in training time
Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.
Next-gen Cloud-based eClinical New technologies are available to leverage Cloud Computing in managing clinical trial data. This paper discusses a next generation eClinical
platform that: - Speeds trial set up
- Accommodates changes with zero downtime
- Integrates effectively with other clinical trial technology systems
It is offered with either software-as-a-service (SaaS), or turnkey infrastructure options in which the user organization operates their own cloud using their IT teams, within their data centers. Read this paper to learn and decide how best to leverage cloud computing’s many strengths for your organization’s particular needs.
Software Engineer – Computational Biology Center
Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.
Apply: www.mskcciscareers.org. Equal opportunity and affirmative action employer.
Bio-IT World proudly presents the Bio-IT World Web Symposia Series covering a broad array of topics within the life sciences and drug development enterprise.
Leveraging BPM to Increase Efficiencies in Clinical Trial Case Management
August 3, 2010 | 1:00 – 2:30 p.m. EST
Sponsored by: Pegasystems
Program Details | Register Here
|
|
|